FDA 510(k) · Actigraph

K181077: ActiGraph CentrePoint Insight Watch (Actigraph)

Actigraph received FDA 510(k) K181077 for ActiGraph CentrePoint Insight Watch, with a decision date of May 24, 2018 (substantially equivalent).

Prescription or OTC: Unknown (no FDA document we parsed states it).

FDA record for K181077FDA summary or statement (PDF)

FDA facts

Official fields for K181077
FDA numberK181077
Pathway510(k)
ApplicantActigraph
Device nameActiGraph CentrePoint Insight Watch
Product codeLEL: Device, Sleep Assessment
Regulation (21 CFR)882.5050
Device classClass 2
Date receivedApr 24, 2018
Decision dateMay 24, 2018
DecisionSubstantially Equivalent (SESE)
510(k) typeSpecial

Source: openFDA device 510(k) data, data through Oct 26, 2026.

Indications for use parsed from FDA documents

The ActiGraph CentrePoint Insight Watch is a small worn activity monitor designed for documenting physical movement associated with applications in physiological monitoring. The device is intended to monitor the activity associated with movement during sleep. The Insight watch can be used to analyze circadian rhythms and assess activity in any instance where quantifiable analysis of physical motion is desirable.

Extracted automatically from FDA's 510(k) summary. It can contain extraction errors and is not a verified quote. Read the wording in the FDA PDF before relying on it.

Predicates parsed from FDA documents

FDA numbers found next to the word "predicate" in the summary. The list can include reference devices; check the PDF for which device is the primary predicate.

Later records that cite K181077

  • K231532 ActiGraph LEAP activity monitor (ActiGraph LEAP) (Actigraph, Jun 23, 2023, LEL)

ChatPPG interpretation

A 510(k) decision of "substantially equivalent" means FDA found the device as safe and effective as a legally marketed predicate. FDA's word for this is cleared, not approved. The clearance covers the device and indications in this submission; it does not extend to other features or versions of the same product that were not part of it. See FDA cleared vs approved.

Product code LEL is "Device, Sleep Assessment", class 2, 21 CFR 882.5050.

Our labels for filtering: claim Sleep, sensor Wrist PPG. These are heuristics, not FDA fields.